Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008469 |
ID: | TCMBANKHE008469 |
植物拉丁名: |
|
功能与主治: | To war m yang and disinhibit water, dispel wind and quicken blood./Congestive cardiac failure, rheumatic heart disease, paroxysmal tachycardia, edema. |
药用植物名: | 铃兰 |
药用部位: | whole herb with root |
TCM_ID_id: | 5913 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000082 | deguelin | C23H22O6 | 394.4 g/mol | CC1(C=CC2=C(O1)C=CC3=C2OC4COC5=CC(=C(C=C5C4C3=O)OC)OC)C | |
| TCMBANKIN000639 | Convallasaponin A | convallasaponin a | C32H52O9 | 580.75 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(CC(C6)OC7C(C(C(CO7)O)O)O)O)C)O)C)C)OC1 |
| TCMBANKIN003133 | convallatoxin | C29H42O10 | 550.64 | CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)C=O)O)O)O | |
| TCMBANKIN004487 | isorhodeasapogenin | C27H44O4 | 432.6 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(C(CC(C6)O)O)C)C)C)OC1 | |
| TCMBANKIN007213 | glucoconvallasaponin a | C38H62O14 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(CC(C6)OC7C(C(C(CO7)O)O)OC8C(C(C(C(O8)CO)O)O)O)O)C)O)C)C)OC1 | ||
| TCMBANKIN015203 | erysimosol | C35H54O14 | 698.8 g/mol | CC1C(C(CC(O1)O)O)OCC2C(C(C(C(O2)OC3CCC4(C5CCC6(C(CCC6(C5CCC4(C3)O)O)C7=CC(=O)OC7)C)CO)O)O)O | |
| TCMBANKIN017629 | (2r,3r)-2',3,5,7-tetrahydroxyflavanone | C15H12O6 | C1=CC=C(C(=C1)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O | ||
| TCMBANKIN019002 | kessoglycol | C15H26O3 | 254.36 g/mol | CC1CC(C2C1CC3C(CC2(OC3(C)C)C)O)O | |
| TCMBANKIN020508 | convallasaponin d | C50H82O21 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(C(CC(C6)OC7C(C(C(C(O7)C)O)OC8C(C(C(CO8)O)O)OC9C(C(C(C(O9)C)O)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)C)C)C)OC1 | ||
| TCMBANKIN022108 | deglucocheirotoxin | C29H42O10 | 550.6 g/mol | CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)C=O)O)O)O | |
| TCMBANKIN023441 | (3 β, 5 β, 25 s)一Spirostan-3-of | ||||
| TCMBANKIN024819 | keioside | C28H32O16 | 624.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)OC)O)O)O)O)O)O | |
| TCMBANKIN026811 | chelidonine | CHEMBL1966935; Stylophorin; Prestwick0_000587; CHEBI:31389; AIDS002651; Prestwick2_000587; NSC646661 (FREE BASE); MEGxp0_001421; Chelidonine; AIDS-002651; BPBio1_000478; Prestwick1_000587; Prestwick3_000587; BSPBio_000434; 5b,6,7,12b,13,14-Hexahydro-13-methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenan-thridin-6-ol;[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridin-6-ol, 5b,6,7,12b,13,14-hexahydro-13-methyl-, (5bR,6S,12bS)-; Chelidonin; NSC406034; SPBio_002653; 476-32-4; C12242; NSC-406034; ACon1_000007 | C20H19NO5 | 353.37 | CN1CC2=C(C=CC3=C2OCO3)C4C1C5=CC6=C(C=C5CC4O)OCO6 |
| TCMBANKIN026874 | convallatoxol | C29H44O10 | 552.65 | CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)CO)O)O)O | |
| TCMBANKIN027536 | convallamarin | 1391-12-4 | C57H94O27 | 1211.3 g/mol | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3CC(CC4C3(C5CCC6C(C5CC4)CC7C6(C(C(O7)(CCC(=C)COC8C(C(C(C(O8)CO)O)O)O)O)C)C)C)OC9C(C(C(C(O9)C)OC1C(C(C(C(O1)CO)O)O)O)O)O)C)O)O)O |
| TCMBANKIN028418 | erysimoside | C35H52O14 | 696.78 | CC1C(C(CC(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)C=O)O)OC7C(C(C(C(O7)CO)O)O)O | |
| TCMBANKIN032760 | glucoconvallasaponin b | C38H62O15 | 758.9 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(CC(C6O)OC7C(C(C(C(O7)CO)O)O)O)O)C)OC8C(C(C(CO8)O)O)O)C)C)OC1 | |
| TCMBANKIN033175 | convallasaponin c | C44H72O16 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(C(CC(C6)OC7C(C(C(CO7)O)O)OC8C(C(C(C(O8)C)O)OC9C(C(C(C(O9)C)O)O)O)O)O)C)C)C)OC1 | ||
| TCMBANKIN034944 | isorhoeadine | C21H21NO6 | 383.4 g/mol | CN1CCC2=CC3=C(C=C2C4C1C5=C(C(O4)OC)C6=C(C=C5)OCO6)OCO3 | |
| TCMBANKIN036050 | (?)-epicatechin | C15H14O6 | |||
| TCMBANKIN036189 | convallasaponin b | C32H52O10 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(CC(C6O)O)O)C)OC7C(C(C(CO7)O)O)O)C)C)OC1 | ||
| TCMBANKIN036845 | isoquercitrin | BDBM84979; FT-0627504; ISOQUERCITRIN | C21H20O12 | 464.376 | C1(c2c([H])c([H])c(O[H])c(O[H])c2[H])=C(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])C(=O)c4c(c([H])c(O[H])c([H])c4O[H])O1 |
| TCMBANKIN039085 | copadiene | 8-ISOPROPYL-1-METHYL-5-METHYLIDENETRICYCLO[4.4.0.0(2),?]DEC-3-ENE; 27597-38-2; (1alpha,6alpha,7alphaH)-2,4(15)-Copadiene; 1-methyl-5-methylidene-8-(propan-2-yl)tricyclo[4.4.0.0;{2,7}]dec-3-ene; 2,4(15)-Copadiene | C15H22 | 202.33 g/mol | CC(C)C1CCC2(C3C1C2C(=C)C=C3)C |
| TCMBANKIN042205 | Periplogenin-3-O-alpha-L-rhamnopyranoside | periplogenin-3-o-alpha-l-rhamnopyranoside; periplogenin-3-o-α-l-rhamnopyranoside | C29H44O9 | 536.73 | [C@@]1([H])(O[H])[C@]([H])(C([H])([H])[H])O[C@@]([H])(O[C@@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@]([H])(C3=C([H])C(=O)OC3([H])[H])C ([H])([H])C4([H])[H])[C@]45O[H])[C@@]5([H])C([H])([H])C6([H])[H])[C@@]6(O[H])C2([H])[H])[C@]([H])(O[H])[C@]1([H])O[H] |
| TCMBANKIN048928 | Bipindogenin-3-O-β-D-allopyranoside | ||||
| TCMBANKIN049504 | glucoerucin | C12H23NO9S3 | 421.507 | O1[C@@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])S\C(\C([H])([H])C([H])([H])C([H])([H])C([H])([H])SC([H])([H])[H])=N/OS(O)(=O)=O | |
| TCMBANKIN058096 | chelidonicacid | AC1NF5P1; 4-oxopyran-2,6-dicarboxylate; I04-10436; CJ-00939; chelidonate; ZB004336; chelidonic acid;Jerva acid;5-18-08-00646 (Beilstein Handbook Reference); AI3-19253; Chelidonic acid; 382272_ALDRICH; 4-Oxo-1,4-pyran-2,6-dicarboxylic acid; TimTec1_001281; gamma-Pyrone-2,6-dicarboxylic acid; SBB000242; Compound xi*; 99-32-1; Compound XI* (Cherry and Hageman); Jervaic acid; NSC3979; 22500_FLUKA; EINECS 202-749-0; C08476; BRN 0163607; 4H-Pyran-2,6-dicarboxylic acid, 4-oxo-; Jervasic acid; .gamma.-Pyrone-2,6-dicarboxylic acid; 4-ketopyran-2,6-dicarboxylic acid; 2,6-Dicarboxyl-4-pyrone; 4-oxopyran-2,6-dicarboxylic acid; 4-Oxo-4H-pyran-2,6-dicarboxylic acid; WLN: T6O DVJ BVQ FVQ; AIDS009896; NSC 3979; AIDS-009896 | C7H4O6 | 184.1 g/mol | C1=C(OC(=CC1=O)C(=O)O)C(=O)O |
| TCMBANKIN058130 | quercetin-３-Ｏ-galactoside | hyperin; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; SMR000466394; C10073; ACon1_000623; Quercetin 3-O-beta-D-galactopyranoside; Quercetin-3-O-galactoside;p Hyperin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-; 482-36-0; Hyperin; Quercetin 3-galactoside; AIDS026341; Hyperasid; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; NSC 407304; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; Quercetin-3-O-galactoside; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Hyperozide; AIDS-026341; MLS000759538; Quercetin 3-D-galactoside; EINECS 207-580-6; Quercetin-3-galactoside; Hyperin (8CI); Hyperoside; 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; 83388_FLUKA; MEGxp0_000392; Hyperosid; Quercetin 3-beta-D-galactopyranoside | C21H19O12- | 463.4 g/mol | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)[O-] |
| TCMBANKIN058131 | hyperoside | quercetin-3-O-beta-galactoside; Quercetin-3-O-Galactoside; Quercetin 3-O-galactoside | C21H20O12 | 464.4 g/mol | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O |
| TCMBANKIN058640 | 2-azetidinecarboxylic acid | VA80038; AKOS004910733; (2S)-(-)-Azetidine-2-carboxylic acid; CHEMBL33592; Azetidinecarboxylic acid; AK-27256; BB 0262160; FT-0634338; NSC72471; CHEBI:38108; BDBM50000108; A-2380; azetidine-2-carboxylic acid, AldrichCPR; ST1010054; azetidin-1-ium-2-carboxylate; Z1318268680; HT782; J-012991; A814215; FT-0600768; EN002094; DL-2-Azetidinecarboxylic acid; EN300-24071; EINECS 219-740-2; MFCD00066660; CTK1A3520; ACT01822; AC-5888; 4CH-013358; Q848; (RS)-AZETIDINE-2-CARBOXYLIC ACID; 20063-89-2; MCULE-1336085891; 517A046; DL-Azetidine-2-carboxylic acid; SC-53260; 4CH-011944; KB-50282; DL-AzeOH; TL80090703; CA-1879; 2-AZETIDINECARBOXYLIC ACID; (R)-azetidine-2-carboxylicacid; 2-Azetidinecarboxylicacid; DB-008923; ACMC-209yxx; AC-23581; (+)-2-AZETIDINECARBOXYLIC ACID; TL8001772; X2014; KS-00000KFF; K-0016; NSC-72471; azetidine-2-carboxylicacid; AZETIDINE-2-CARBOXYLICACID (L-); 7729-30-8 Azetidine-2-carboxylic acid; AC1NRUXC; Azetidine-2-carboxylic acid; AC-23205; azetidine-2-carboxylate; RP00426; S14-2650; (+/-)-2-AZETIDINECARBOXYLIC ACID; IADUEWIQBXOCDZ-UHFFFAOYSA-N; (RS)-2-AZIRIDINECARBOXYLIC ACID; F8887-4126; KB-47479; A9783; TX-012237; MolPort-002-471-062; SY013679; (+-)-2-Azetidinecarboxylic acid; AN-10538; AC1L29PE; AM20090145; I04-1348; ALBB-023626; QC-9589; D,L-AzeOH; I04-0055; GS-4253; BR-27256; CS-M0178; SCHEMBL122166; AC1Q74O1; DL-H-AZE-OH; 2-Azetidinecarboxylic acid, (S)- (9CI); 2517/4/6; DB-067333; 1-Azetidinecarboxylicacid, 2-(aminocarbonyl)-, 1,1-dimethylethyl ester, (2S)-; J-519619; D,L-Azetidine-2-carboxylic Acid; PB12060; AB0002316; ANW-50569;azetidine-2-carboxylic acid | C4H7NO2 | 101.1 | C1CNC1C(=O)O |
| TCMBANKIN060249 | sarmentogenin-3-O-α-L-rhamnopyranoside | C29H44O9 | 536.7 g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3C(CC5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)O)O | |
| TCMBANKIN060258 | convalloside | C35H52O15 | 712.8 g/mol | CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)C=O)O)O)OC7C(C(C(C(O7)CO)O)O)O | |
| TCMBANKIN060505 | isorhodeasapogenin | C27H44O4 | 432.6 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(C(CC(C6)O)O)C)C)C)OC1 | |
| TCMBANKIN061537 | peristrophamide | peristrophamide i | C9H9NO4 | COC1=C(C=C2C(=C1)NC(=O)O2)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab